• 1
    Hsiang MS, Abeyasinghe R, Whittaker M, Feachem RG. Malaria elimination in Asia-Pacific: an under-told story. Lancet 2010; 375:15861587.
  • 2
    Feachem RG, Phillips AA, Targett GA, Snow RW. Call to action: priorities for malaria elimination. Lancet 2010; 376:15171521.
  • 3
    Schlagenhauf P, Petersen E. Standby emergency treatment of malaria in travelers: experience to date and new developments. Expert Rev Anti Infect Ther 2012; 10:537546.
  • 4
    Bannister B, Hatz C, Toovey S, et al. The role of standby emergency medication for falciparum malaria: current opinion. Travel Med Infect Dis 2004; 2:119126.
  • 5
    Schlagenhauf P, Steffen R, Tschopp A, et al. Behavioural aspects of travellers in their use of malaria presumptive treatment. Bull World Health Organ 1995; 73:215221.
  • 6
    Newton PN, Green MD, Fernandez FM, et al. Counterfeit anti-infective drugs. Lancet Infect Dis 2006; 6:602613.
  • 7
    Shanks G. Control and elimination of Plasmodium vivax. Adv Parasitol 2012; 80:301341.
  • 8
    Roukens AH, Berg J, Barbey A, Visser LG. Performance of self-diagnosis and standby treatment of malaria in international oilfield service employees in the field. Malar J 2008; 7:128.
  • 9
    Jelinek T, Amsler L, Grobusch MP, Nothdurft HD. Self-use of rapid tests for malaria diagnosis by tourists. Lancet 1999; 354:1609.
  • 10
    Mali S, Kachur SP, Arguin PM, et al. Malaria surveillance—United States, 2010. MMWR Surveill Summ 2012; 61:117.
  • 11
    MalERA. A research agenda for malaria eradication: drugs. PLoS Med 2011; 8:e1000402.
  • 12
    Shanks GD, Magill AJ, Freedman DO, et al. Drug-free holidays: pre-travel versus during travel malaria chemoprophylaxis. Am J Trop Med Hyg 2007; 77:12.
  • 13
    Nasveld PE, Edstein MD, Reid M, et al. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother 2011; 54:792798.